In an exclusive interview ahead of SynBioBeta 2026, co-founder and Stanford Professor Jennifer Dionne outlines how Pumpkinseed's nanophotonic chip platform is opening the proteome to investigation at a resolution and scale the field has never had before — and why that changes everything for drug discovery, AI biology, and medicine.